- Category
- Micro (2020-21)
- Udyam number
- UDYAM-MH-33-0050551

Golden Mist Pharmaceuticals Private Limited
About Golden Mist Pharmaceuticals Private Limited
Data last updated:
Golden Mist Pharmaceuticals Private Limited is a private limited company based in Vasai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 14 December 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24290MH2020PTC351767. Its GSTIN is 27AAICG7245C1ZN (Maharashtra). The company holds 4 GST registrations, all of them active.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Mohammad Gulam and Mohammed Asif Shaikh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at To Gala No. 106 1st Flr Bldg No. 2/A, S.No. 33 H.No. 1 Rajprabha Land Mark Ind. Est Vasai Maharashtra India 401208., Maharashtra, India – 401208.
As per the financials filed for FY 2025, the company reported a revenue of ₹5.92 Cr, a decline of 1% compared to the previous year. For the same year it recorded a net profit of ₹1.72 Cr (net margin 29.1%) and EBITDA of ₹2.47 Cr (EBITDA margin 41.7%). Revenue has grown at a compounded annual rate (CAGR) of 15% over three years.
As per MCA filings, the company has open charges of ₹60 Lakh on record.
Golden Mist Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-33-0050551).
Company details
Recognitions & Rankings of Golden Mist Pharmaceuticals
Contact details
Golden Mist Pharmaceuticals Private Limited's registered office is in Vasai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressTo Gala No. 106 1st Flr Bldg No. 2/A, S.No. 33 H.No. 1 Rajprabha Land Mark Ind. Est Vasai Maharashtra India 401208., Maharashtra, India – 401208
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Golden Mist Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Golden Mist Pharmaceuticals is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations |
To see the full business activity and turnover split of Golden Mist Pharmaceuticals Private Limited, buy the company report.
Financials of Golden Mist Pharmaceuticals Private Limited
FY 2025 filings availableGolden Mist Pharmaceuticals Private Limited reported revenue of ₹5.92 Cr (down 1% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 1% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 15%. EBITDA rose 6% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.47 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.72 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 41.7% | ||||
| Net Profit Margin | 29.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Golden Mist Pharmaceuticals Private Limited, buy the company report.
Board of directors of Golden Mist Pharmaceuticals Private Limited
Golden Mist Pharmaceuticals has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mohammad Gulam Also directs: Unifab Pharmaceuticals Private Limited | Additional Director | 28 Aug 2021 | 5 Years 2 Months | Current |
| Mohammed Asif Shaikh Also directs: Unifab Pharmaceuticals Private Limited | Additional Director | 28 Aug 2021 | 5 Years 2 Months | Current |
| Shreeja Vijay Kumar | Additional Director | 21 Apr 2023 | 3 Years 6 Months | Current |
Auditor
Golden Mist Pharmaceuticals Private Limited is audited by DSMR & Co. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| DSMR & Co. | FY 2023 | 128085W |
Shareholding
The shareholding of Golden Mist Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Golden Mist Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 03 Feb 2025 | 101087880 | Hdfc Bank Limited | ₹60 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Golden Mist Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Golden Mist Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Golden Mist Pharmaceuticals Private Limited has 1 active EPFO establishment as of Nov 12, 2026.
GST
Golden Mist Pharmaceuticals has 4 GST registrations: 4 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAICG7245C1ZN | Maharashtra | Active | 09 Feb 2021 |
| 27AAICG7245C2ZM | Maharashtra | Active | 18 Nov 2021 |
| 27AAICG7245C3ZL | Maharashtra | Active | 25 Nov 2021 |
| 27AAICG7245C4ZK | Maharashtra | Active | 26 Nov 2021 |
To see the full GST registrations and return filing status of Golden Mist Pharmaceuticals Private Limited, buy the company report.
Recent activity
Golden Mist Pharmaceuticals Private Limited has 5 board changes on record since 2021: 3 appointments and 2 cessations. The latest: Shreeja Vijay Kumar was appointed as Additional Director on 21 Apr 2023.
Frequently asked questions
Golden Mist Pharmaceuticals is an active private limited company based in Vasai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 14 December 2020 (6+ years old) and is registered under CIN U24290MH2020PTC351767.
Golden Mist Pharmaceuticals has 3 current directors:
- Mohammad Gulam - Additional Director
- Mohammed Asif Shaikh - Additional Director
- Shreeja Vijay Kumar - Additional Director
The latest financial statements of Golden Mist Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Golden Mist Pharmaceuticals is 27AAICG7245C1ZN, registered in Maharashtra. The company has 4 GST registrations in all, of which 4 are active. Other active GSTINs include 27AAICG7245C2ZM (Maharashtra), 27AAICG7245C3ZL (Maharashtra), 27AAICG7245C4ZK (Maharashtra).
The CIN (Corporate Identification Number) of Golden Mist Pharmaceuticals is U24290MH2020PTC351767. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Golden Mist Pharmaceuticals was incorporated on 14 December 2020, making it 6+ years old. It is registered with the Registrar of Companies, Mumbai.
Shreeja Vijay Kumar was appointed as Additional Director on 21 Apr 2023. Smita Pillai ceased to be Director on 01 Sep 2021. Bipasha Bindulal Babu ceased to be Director on 28 Aug 2021. Golden Mist Pharmaceuticals has 5 board changes on record in total.
Yes, Golden Mist Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-33-0050551).
The registered office of Golden Mist Pharmaceuticals is at To Gala No. 106 1st Flr Bldg No. 2A, S.No. 33 H.No. 1 Rajprabha Land Mark Ind. Est Vasai Maharashtra India 401208., Maharashtra, India – 401208.
Golden Mist Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

